Educational Intervention for Cancer Knowledge

Recruiting in Palo Alto (17 mi)

Overseen byStacy W. Gray

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: City of Hope Medical Center

No Placebo Group

Trial Summary

What is the purpose of this trial?

This clinical trial studies the effectiveness of a web-based cancer education tool called Helping Oncology Patients Explore Genomics (HOPE-Genomics) in improving patient knowledge of personal genomic testing results and cancer and genomics in general. HOPE-Genomics is a web-based education tool that teaches cancer/leukemia patients, and patients who may be at high-risk for developing cancer, about genomic testing and provide patients with information about their own genomic test results. The HOPE-Genomics tool may improve patient's genomic knowledge and quality of patient-centered care. In addition, it may also improve education and care quality for future patients.

Eligibility Criteria

This trial is for English-speaking adults over 18 with lung, breast, colorectal, pancreatic, ovarian or prostate cancer who are undergoing genomic sequencing. They must be enrolled in a specific review board and have a performance status indicating they can care for themselves.

Inclusion Criteria

I have been diagnosed with lung, breast, colorectal, pancreatic, ovarian, or prostate cancer.

My cancer has been genetically sequenced.

I am able to care for myself and perform daily activities.

See 3 more

Exclusion Criteria

I am unable to understand and give consent for treatment.

Treatment Details

Interventions

HOPE-Genomics (Behavioural Intervention)

Trial OverviewThe trial tests the HOPE-Genomics web tool designed to educate cancer patients about their own genomic test results and general genomics knowledge. It aims to see if this improves understanding of personal testing outcomes and overall patient-centered care quality.

Participant Groups

3Treatment groups

Experimental Treatment

Active Control

Group I: Arm III (HOPE-Genomics, genomics test results)Experimental Treatment2 Interventions

Patients view HOPE-Genomics tool (containing educational content) over 15-20 minutes before their sequencing results are available. Patients also receive their genomics test results both from their clinician and from the HOPE-Genomics tool.

Group II: Arm II (genomics test results, HOPE-Genomics)Experimental Treatment3 Interventions

Patients receive their genomics test results both from their clinician and from the HOPE-Genomics tool. Patients then view HOPE-Genomics tool over 15-20 minutes after their results are available.

Group III: Arm I (usual care)Active Control2 Interventions

Patients receive education pamphlet about WES and have their genomics test results returned by their clinician in a typical manner.